|
2007P-0316:
Risperdal (Risperidone) Tablets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 08/06/2007
|
| 08/08/2007
|
| Drug Industry
|
| Teva Pharmaceuticals
USA
|
|
|
|
|
|
|
| Table
of Contents
|
|
|
|
|
| Signature:
|
| Deborah A. Jaskot, M.S., RAC
|
|
|
|
|
| ACK1
|
| 08/08/2007
|
| 08/08/2007
|
| Federal Government
|
| FDA/DDM to Teva Pharmaceuticals
USA
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Lyle D. Jaffe
|
|
|
|
|
|
Top
| Up
Page last updated:
August 14, 2007
|
